Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination Stimulation

被引:62
作者
Abbasi-Kangevari, Mohsen [1 ]
Ghamari, Seyyed-Hadi [2 ]
Safaeinejad, Fahimeh [1 ]
Bahrami, Soheyl [3 ]
Niknejad, Hassan [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Social Determinants Hlth Ctr, Student Res Comm, Tehran, Iran
[3] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria
关键词
angiogenesis; anti-inflammation; antioxidant; amniotic membrane; mesenchymal stem cell; multiple sclerosis; neurogenesis; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NEUROTROPHIC FACTOR; MEMBRANE; TRANSPLANTATION; PATHOGENESIS; MODEL; STRATEGIES; MATRIX;
D O I
10.3389/fimmu.2019.00238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is an inflammatory and degenerative disorder of the central nervous system with unknown etiology. It is accompanied by demyelination of the nerves during immunological processes in the presence of oxidative stress, hypoxia, cerebral hypo-perfusion, and dysregulation in matrix metalloproteinases (MMPs). Human amniotic mesenchymal stem cells (hAMSCs) as pluripotent stem cells possess some conspicuous features which could be of therapeutic value in MS therapy. hAMSCs could mimic the cascade of signals and secrete factors needed for promoting formation of stable neovasculature and angiogenesis. hAMSCs also have immunomodulatory and immunosuppressive effects on inflammatory processes and reduce the activity of inflammatory cells, migration of microglia and inhibit recruitment of certain immune cells to injury sites. hAMSCs attenuate the oxidative stress supported by the increased level of antioxidant enzymes and the decreased level of lipid peroxidation products. Furthermore, hAMSCs enhance neuroprotection and neurogenesis in brain injuries by inhibition of inflammation and promotion of neurogenesis. hAMSCs could significantly increase the expression of neurotrophic factors, which prevents neurons from initiating programmed cell death and improves survival, development, and function of neurons. In addition, they induce differentiation of neural progenitor cells to neurons. hAMSCs could also inhibit MMPs dysregulation and consequently promote the survival of endothelial cells, angiogenesis and the stabilization of vascular networks. Considering the mentioned evidences, we hypothesized here that hAMSCs and their conditioned medium could be of therapeutic value in MS therapy due to their unique properties, including immunomodulation and inflammation suppression; angiogenesis promotion; oxidative stress inhibition; neurogenesis induction and neuroprotection; matrix metalloproteinases regulation; and remyelination stimulation.
引用
收藏
页数:8
相关论文
共 73 条
[1]   The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS) [J].
Al Jumah, Mohammed A. ;
Abumaree, Mohamed H. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (07) :9298-9331
[2]   Unravelling neurodegeneration in multiple sclerosis [J].
Bermel, Robert A. .
LANCET NEUROLOGY, 2017, 16 (10) :764-766
[3]   Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases [J].
Chelluboina, Bharath ;
Nalamolu, Koteswara Rao ;
Mendez, Gustavo G. ;
Klopfenstein, Jeffrey D. ;
Pinson, David M. ;
Wang, David Z. ;
Veeravalli, Krishna Kumar .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (04) :1360-1369
[4]   Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis [J].
Chen, Xiaohong ;
Ma, Lili ;
Jiang, Ying ;
Chen, Shaoqiong ;
Zhu, Cansheng ;
Liu, Mei ;
Ma, Xiaomeng ;
Zhu, Dongliang ;
Liu, Yingying ;
Peng, Fuhua ;
Wang, Qing ;
Pi, Rongbiao .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 686 (1-3) :124-129
[5]   Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells [J].
Chiesa, Sabrina ;
Morbelli, Silvia ;
Morando, Sara ;
Massollo, Michela ;
Marini, Cecilia ;
Bertoni, Arinna ;
Frassoni, Francesco ;
Bartolome, Soraya Tabera ;
Sambuceti, Gianmario ;
Traggiai, Elisabetta ;
Uccelli, Antonio .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (42) :17384-17389
[6]   Multiple sclerosis [J].
Compston, Alastair ;
Coles, Alasdair .
LANCET, 2008, 372 (9648) :1502-1517
[7]   Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue [J].
Dabrowski, Filip A. ;
Burdzinska, Anna ;
Kulesza, Agnieszka ;
Sladowska, Anna ;
Zolocinska, Aleksandra ;
Gala, Kamila ;
Paczek, Leszek ;
Wielgos, Miroslaw .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (11) :1758-1768
[8]   Regulatory T cells in multiple sclerosis and myasthenia gravis [J].
Danikowski, K. M. ;
Jayaraman, S. ;
Prabhakar, B. S. .
JOURNAL OF NEUROINFLAMMATION, 2017, 14
[9]   Oligodendrogenesis in the normal and pathological central nervous system [J].
El Waly, Bilal ;
Macchi, Magali ;
Cayre, Myriam ;
Durbec, Pascale .
FRONTIERS IN NEUROSCIENCE, 2014, 8
[10]   Matrix Metalloproteinase 9 Is Decreased in Natalizumab-Treated Multiple Sclerosis Patients at Risk for Progressive Multifocal Leukoencephalopathy [J].
Fissolo, Nicolas ;
Pignolet, Beatrice ;
Matute-Blanch, Clara ;
Trivino, Juan Carlos ;
Miro, Berta ;
Mota, Miriam ;
Perez-Hoyos, Santiago ;
Sanchez, Alex ;
Vermersch, Patrick ;
Ruet, Aurelie ;
Vermersch, Patrick ;
Ruet, Aurelie ;
de Seze, Jerome ;
Labauge, Pierre ;
Vukusic, Sandra ;
Papeix, Caroline ;
Almoyna, Laurent ;
Tourbah, Ayman ;
Clavelou, Pierre ;
Moreau, Thibault ;
Pelletier, Jean ;
Lebrun-Frenay, Christine ;
Montalban, Xavier ;
Brassat, David ;
Comabella, Manuel .
ANNALS OF NEUROLOGY, 2017, 82 (02) :186-195